Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Insulin Therapy in Treating Post-Transplant Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Must be followed by the Inova Fairfax Hospital transplantation program for post-transplant care~2. Diabetes mellitus inadequately responsive to lifestyle modification and non-insulin hypoglycemic medication~3. Need for subcutaneous insulin therapy (after discontinuation of IV insulin therapy, if it was required)~4. Ability to read consent form and give consent in English.~Exclusion Criteria:~1. Use of insulin or non-insulin hypoglycemic medication before transplantation~2. Cystic fibrosis patients~3. Age \< 18 years of age~4. Pregnancy~5. Non-English speaking subjects

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- insulin isophane (Type: ACTIVE_COMPARATOR): daily dose will be titrated based on fasting morning glucose values
- insulin glargine (Type: ACTIVE_COMPARATOR): daily dose will be titrated based on fasting morning glucose values

Based on this trial design, predict the completion outcome and termination type (if applicable).